• 1
    Montreuil J, Bouquelet S, Debray H, Fournet B, Spik G, Strecker G. Glycoproteins. In: ChaplinM F, KennedyJF, eds. Carbohydrate analysis: a practical approach. Oxford : IRL Press Ltd, 1982: 143204.
  • 2
    Axford JS, Sumar N, Alavi A et al. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J Clin Invest 1992; 89:102131.
  • 3
    Field MC, Dwek RA, Edge CJ Rademacher TW. O-linked oligosaccharides from human scrum immunoglobulin Al. Biochem Soc Trans 1989; 17:10345.
  • 4
    Andre PM, Le Pogamp P, Chevet D. Impairment of jacalin binding to scrum IgA in IgA nephropathy. J Clin Lab Anal 1990; 4:1159.
  • 5
    Hiki Y, Iwase H, Saitoh M et al. O-linked oligosaccharide (Galβ13GalNAc) on IgA hinge region in IgA nephropathy. Abstract, IgA Nephropathy, The 25th Year' International Symposium, Nancy, France, 1992. Basle : Karger.
  • 6
    Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S. Defective galactosylation and clearance of IgAl molecules as a possible etiopathogenic factor in IgA nephropathy. In: BeneMC, FaureGC, KesslerM, eds. IgA nephropathy: The 25th Year. Contrib Nephrol 1993; 104:17282.
  • 7
    Sumar N, Bodman KB, Rademacher TW et al. Analysis of glycosylation changes in IgG using lectins. J Immunol Methods 1990; 131:12736.
  • 8
    Sharon N, Lis H. Carbohydrate specificity. In: Lectins. London : Chapman and Hall, 1989: 3746.
  • 9
    Griffiths HR, Lunec J. The effects of oxygen free radicals on the carbohydrate moiety of IgG. FEBS Lett 1989; 245:9599.
  • 10
    Pemberton RT. Studies on the human rod cell agglutinins of the swan mussel (Anodonta cygnea). Vox Sang 1969; 16:45764.
  • 11
    Monteiro RC, Halbwachs-Mecarelli L. Roque-Barreira MC. Noel L-H, Berger J. Lesavre P Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 1985; 28:66671.
  • 12
    Monteiro RC, Chevailler A, Noel L-H, Lesavre P. Serum IgA preferentially binds to cationic polypeptides in IgA nephropathy. Clin Exp Immunol 1988; 73:3006.
  • 13
    Harada T, Hobby P. Courteau M, Knight JF, Williams DG. Charge distribution of plasma IgA in IgA nephropathy. Clin Exp Immunol 1989; 77:2114.
  • 14
    Gorter A, Hiemstra PS, van den Voort EAM, van Es LA, Daha MR. Binding of human IgA1 to rat peritoneal macrophages. Immunology 1988; 64:20712.
  • 15
    Gomez-Guerrero C, Gonzalez E, Egido J. Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol 1993; 151:717281.
  • 16
    Allen AC, Greer MR. Combe C et al. Binding of human IgA to human leucocytes and mesangial cells. J Amer Soc Nephrol 1994; 5:739 (Abstr.).
  • 17
    Coppo R, Amore A, Gianoglio B et al. Serum IgA and macromolecular IgA reacting with mesangial matrix components. In: BeneMC, FaureGC, KesslerM, eds. IgA nephropathy: The 25th Year. Contrib Nephrol 1993; 104:16271.
  • 18
    Roccatello D, Picciotto G, Torchio M et al. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients: the role of asialoglycoprotein receptors. Lab Invest 1993; 69:71423.
  • 19
    Hiki Y, Iwasc H, Tanaka A. TOFMS analysis for precise structure of O-glycans in IgA1 hinge region. J Amer Soc Nephrol 1994; 5:831 (Abstr.).
  • 20
    Berger EG, Kozdrowski I. Permanent mixed-field polyagglutinable erythrocytes lack galactosyltransferase activity. FEBS Lett 1978; 93:1058.
  • 21
    Cartron J-P, Andreu G, Cartron J, Bird GWG, Salmon C, Gerbal A. Demonstration of T-transferase deficiency in Tn-polyagglutinable blood samples. Eur J Biochem 1978; 92:1119.
  • 22
    Cartron JP, Nurden AT. Galactosyltransferase and membrane glycoprotein abnormality in human platelets from Tn-syndrome donors. Nature 1979; 282:6213.
  • 23
    Blumenfeld OO, Lalezari P, Khorshidi M, Puglia K, Fukada M. O- linked oligosaccharides of glycophorin A and B in erythrocytes of two individuals with the Tn polyagglutinability syndrome. Blood 1992; 80:238895.
  • 24
    Thunher M, Clausen H, Fierz W, Lanzavecchia A, Berger EG. T cell clones with normal or defective O-gatactosylation from a patient with permanent mixed-field polyagglutinability. Eur J Immunol 1992; 22:183542.